Cleared Traditional

K914815 - IL TEST(TM) BENZODIAZEPINE

K914815 is the FDA 510(k) clearance for IL TEST(TM) BENZODIAZEPINE by Instrumentation Laboratory CO. It is a Class 2 Chemistry device (product code JXM) cleared through the Traditional 510(k) pathway after a 94-day FDA review.

K914815 · Instrumentation Laboratory CO · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1992
Decision
94d
Days
Class 2
Risk

K914815 is an FDA 510(k) clearance for the IL TEST(TM) BENZODIAZEPINE. Classified as Enzyme Immunoassay, Benzodiazepine (product code JXM), Class II - Special Controls.

Submitted by Instrumentation Laboratory CO (Lexington, US). The FDA issued a Cleared decision on January 27, 1992 after a review of 94 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.3170 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Instrumentation Laboratory CO devices

Submission Details

510(k) Number K914815 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 25, 1991
Decision Date January 27, 1992
Days to Decision 94 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
6d slower than avg
Panel avg: 88d · This submission: 94d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JXM Enzyme Immunoassay, Benzodiazepine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3170
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JXM Enzyme Immunoassay, Benzodiazepine

All 63
Devices cleared under the same product code (JXM) and FDA review panel - the closest regulatory comparables to K914815.
EMIT(R) D.A.U. BENZODIAZEPINE ASSAY
K931536 · Syva Co. · May 1993
EMIT(R) II BENZODIAZEPINE ASSAY
K926067 · Syva Co. · Jan 1993
EMIT D.A.U BENZODIAZEPINE ASSAY
K915501 · Syva Co. · Feb 1992
ABUSCREEN(R) ONLINE(TM) FOR BENZODIAZEPINES
K914509 · Roche Diagnostic Systems, Inc. · Nov 1991
ABUSCREEN ONTRAK FOR BENZODIAZEPINE
K910590 · Roche Diagnostic Systems, Inc. · Apr 1991
EMIT II BENZODIAZEPINE ASSAY
K910376 · Syva Co. · Feb 1991